Protox Appoints Dr. Alexander Giaquinto to Board of Directors
Protox Therapeutics Inc. , a leader in the development of receptor targeted fusion proteins, announced that it has appointed Dr. Alexander R. Giaquinto to its Board of Directors. Dr. Giaquinto is currently the Senior Vice President of Regulatory Affairs and Quality Assurance for Regado Biosciences Inc. and acts as an independent consultant to several pharmaceutical companies. [more...]
|
|
|
